Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
68
MREO Quote, Financials, Valuation and Earnings
Last price:
$2.32
Seasonality move
:
15.38%
Day range:
$2.27 - $2.34
52-week range:
$1.47 - $3.84
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
721.31x
P/B ratio:
7.88x
Volume:
872.3K
Avg. volume:
2.2M
1-year change:
-38.73%
Market cap:
$367.3M
Revenue:
--
EPS (TTM):
-$0.26
Earnings Data
Next earnings date for MREO
Mar 25
2026
Most recent earnings per share
-$0.04
Missed by $0.04
(Nov 10/2025)
Consensus Estimate
-$0.00
(Nov 10/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MREO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/25/2026 | Q4 | $17.3M | -- | -- | -$0.01 | -- |
| 11/10/2025 | Q3 | $5M | -- | -$0.04 | -$0.00 | -$0.04 |
| 08/12/2025 | Q2 | -- | $505.9K | -$0.09 | -$0.01 | -$0.08 |
| 05/15/2025 | Q1 | $15.9M | -- | -$0.08 | -$0.01 | -$0.07 |
| 03/26/2025 | Q4 | -- | -- | -$0.05 | -$0.01 | -$0.03 |
| 11/12/2024 | Q3 | -- | -- | -$0.10 | -$0.02 | -$0.08 |
| 08/13/2024 | Q2 | -- | -- | -$0.10 | -$0.01 | -$0.09 |
| 05/15/2024 | Q1 | -- | -- | -$0.05 | -- | -- |
| 12/31/2023 | Q4 | -- | $1M | -$0.05 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.03 | -- | -- |
| 03/31/2022 | Q4 | -- | -- | -- | -- | -- |
| 11/08/2021 | Q3 | -- | -- | -- | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -- | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -- | -- | -- |
Mereo BioPharma Group Plc Earnings Questions
-
How Much did Mereo BioPharma Group Plc Generate in Revenue Last Quarter?
Mereo BioPharma Group Plc reported -- worth of top line sales in its most recent quarter.
-
Did Mereo BioPharma Group Plc Beat Earnings Last Quarter?
Mereo BioPharma Group Plc announced earnings per share of -$0.04 which represents a miss of analyst forecast a -$0.00 per share.
-
Is Mereo BioPharma Group Plc Profitable?
Mereo BioPharma Group Plc reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Mereo BioPharma Group Plc EPS Next Year?
Mereo BioPharma Group Plc's earnings are forecast to decrease from -$0.29 per share to -$0.05 per share next year representing a decrease of -82.06%.
-
When is Mereo BioPharma Group Plc's Earnings Date?
Mereo BioPharma Group Plc's next earnings date is March 25, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
